A role for paralog-specific sumoylation in histone deacetylase 1 stability
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A role for paralog-specific sumoylation in histone deacetylase 1 stability
Authors
Keywords
-
Journal
Journal of Molecular Cell Biology
Volume 5, Issue 6, Pages 416-427
Publisher
Oxford University Press (OUP)
Online
2013-09-26
DOI
10.1093/jmcb/mjt032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function
- (2013) M. R. Heideman et al. BLOOD
- Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice
- (2013) O. M. Dovey et al. BLOOD
- A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
- (2013) F. Santoro et al. BLOOD
- Histone Deacetylase 2 (HDAC2) Regulates Chromosome Segregation and Kinetochore Function via H4K16 Deacetylation during Oocyte Maturation in Mouse
- (2013) Pengpeng Ma et al. PLoS Genetics
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- (2012) Alexei F. Kisselev et al. CHEMISTRY & BIOLOGY
- HDAC inhibitors for the treatment of cutaneous T-cell lymphomas
- (2012) Sophia Rangwala et al. Future Medicinal Chemistry
- Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis
- (2011) Jennifer Jurkin et al. CELL CYCLE
- Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung
- (2011) Yoshihiro Minamiya et al. LUNG CANCER
- Chemopreventive Agent 3,3'-Diindolylmethane Selectively Induces Proteasomal Degradation of Class I Histone Deacetylases
- (2010) Y. Li et al. CANCER RESEARCH
- Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
- (2010) Cliona Grant et al. Expert Review of Anticancer Therapy
- Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells
- (2010) Fernando Warleta et al. FOOD AND CHEMICAL TOXICOLOGY
- In VivoIdentification of Sumoylation Sites by a Signature Tag and Cysteine-targeted Affinity Purification
- (2010) Henri A. Blomster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Proteomics Approach to Identify SUMOylated Proteins and Their Modification Sites in Human Cells
- (2010) Frederic Galisson et al. MOLECULAR & CELLULAR PROTEOMICS
- How accurate are cancer cell lines?
- (2010) Brendan Borrell NATURE
- Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
- (2010) Qiliang Cai et al. PLoS One
- Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation
- (2010) O. M. Dovey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression
- (2009) J. Suzuki et al. CLINICAL CANCER RESEARCH
- PARP-1 transcriptional activity is regulated by sumoylation upon heat shock
- (2009) Nadine Martin et al. EMBO JOURNAL
- Substantially reduced expression of PIAS1 is associated with colon cancer development
- (2009) Domenico Coppola et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Protection from Isopeptidase-Mediated Deconjugation Regulates Paralog-Selective Sumoylation of RanGAP1
- (2009) Shanshan Zhu et al. MOLECULAR CELL
- An additional role for SUMO in ubiquitin-mediated proteolysis
- (2009) Marie-Claude Geoffroy et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
- (2008) W. Weichert et al. CLINICAL CANCER RESEARCH
- Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression
- (2008) E. C. Brantley et al. CLINICAL CANCER RESEARCH
- Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML
- (2008) Stefan R. Weisshaar et al. FEBS LETTERS
- Small Ubiquitin-related Modifier (SUMO) Binding Determines Substrate Recognition and Paralog-selective SUMO Modification
- (2008) Jianmei Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
- Mechanism and Consequences for Paralog-Specific Sumoylation of Ubiquitin-Specific Protease 25
- (2008) Erik Meulmeester et al. MOLECULAR CELL
- RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
- (2008) Michael H. Tatham et al. NATURE CELL BIOLOGY
- Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
- (2008) Valérie Lallemand-Breitenbach et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started